Afficher la notice abrégée

Position paper of the French Society of Respiratory Diseases regarding pharmacological treatment optimization for stable COPD in 2021

dc.rights.licenseopenen_US
hal.structure.identifierCentre de recherche Cardio-Thoracique de Bordeaux [Bordeaux] [CRCTB]
dc.contributor.authorZYSMAN, Maeva
dc.contributor.authorBAPTISTA, Bruno Ribeiro
dc.contributor.authorSOUMAGNE, Thibaud
dc.contributor.authorDA SILVA, Vanessa Marques
dc.contributor.authorMARTIN, Clemence
dc.contributor.authorDE MENONVILLE, Charlotte Thibault
dc.contributor.authorBOYER, Laurent
dc.contributor.authorDEGANO, Bruno
dc.contributor.authorBURGEL, Pierre-Regis
dc.contributor.authorPEREZ, Thierry
dc.contributor.authorBOURDIN, Arnaud
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorRAHERISON-SEMJEN, Chantal
dc.contributor.authorPEGLIASCO, Herve
dc.contributor.authorPIPERNO, Daniel
dc.contributor.authorZANETTI, Christophe
dc.contributor.authorMOREL, Hughes
dc.contributor.authorDELCLAUX, Bertrand
dc.contributor.authorDELAFOSSE, Christian
dc.contributor.authorLORENZO, Alain
dc.contributor.authorHOUSSET, Bruno
dc.contributor.authorMORELOT-PANZINI, Capucine
dc.contributor.authorCHABOT, Francois
dc.contributor.authorDEVILLIER, Philippe
dc.contributor.authorDESLEE, Gaetan
dc.contributor.authorROCHE, Nicolas
dc.date.accessioned2022-03-09T08:06:08Z
dc.date.available2022-03-09T08:06:08Z
dc.date.issued2022-05
dc.identifier.issn2590-0412en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/136391
dc.description.abstractEnThe previous French Society of Respiratory Diseases (SPLF, Société de Pneumologie de Langue Française) position paper on pharmacological treatment optimization in stable COPD was released in 2016 [1]. Many randomized clinical trials assessing new pharmacological treatments/devices have been published since then. The concept of a personalized approach in COPD based on phenotypes, endotypes, and treatable traits generates a growing interest although much uncertainty remains regarding the best way to optimize pharmacological therapy in COPD, and especially regarding the use of biomarkers in addition to clinical characteristics. Therefore, existing propositions and guidelines need to be regularly updated, as recently done by several national or international societies or working groups including Global Obstructive Lung Disease, GOLD [2], National Institute for Health and Care Excellence, NICE [3], European respiratory Society, ERS [4] and American Thoracic Society, ATS [5]. In this context, the SPLF decided to update its position on pharmacological treatment optimization in stable COPD in 2021. A working group expert in COPD, representative of pulmonologists, pharmacists, physiologists and general practitioners, reviewed the literature published between 2016 and 2021 [6]. The basis for this position paper is derived from randomized controlled trials, large cohorts, real-world-evidence and expert advices.
dc.language.isoENen_US
dc.title.enPosition paper of the French Society of Respiratory Diseases regarding pharmacological treatment optimization for stable COPD in 2021
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.resmer.2022.100889en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed35219225en_US
bordeaux.journalRespiratory Medicine and Researchen_US
bordeaux.volume81en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamEPICENE_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.exportfalse
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Respiratory%20Medicine%20and%20Research&rft.date=2022-05&rft.volume=81&rft.eissn=2590-0412&rft.issn=2590-0412&rft.au=ZYSMAN,%20Maeva&BAPTISTA,%20Bruno%20Ribeiro&SOUMAGNE,%20Thibaud&DA%20SILVA,%20Vanessa%20Marques&MARTIN,%20Clemence&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée